• Medientyp: E-Artikel
  • Titel: FAS2FURIOUS: Moderate-Throughput Secreted Expression of Difficult Recombinant Proteins in Drosophila S2 Cells
  • Beteiligte: Coker, Jesse A.; Katis, Vittorio L.; Fairhead, Michael; Schwenzer, Anja; Clemmensen, Stine B.; Frandsen, Bent U.; de Jongh, Willem A.; Gileadi, Opher; Burgess-Brown, Nicola A.; Marsden, Brian D.; Midwood, Kim S.; Yue, Wyatt W.
  • Erschienen: Frontiers Media SA, 2022
  • Erschienen in: Frontiers in Bioengineering and Biotechnology
  • Sprache: Nicht zu entscheiden
  • DOI: 10.3389/fbioe.2022.871933
  • ISSN: 2296-4185
  • Schlagwörter: Biomedical Engineering ; Histology ; Bioengineering ; Biotechnology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p>Recombinant protein expression in eukaryotic insect cells is a powerful approach for producing challenging targets. However, due to incompatibility with standard baculoviral platforms and existing low-throughput methodology, the use of the <jats:italic>Drosophila melanogaster</jats:italic> “S2” cell line lags behind more common insect cell lines such as Sf9 or High-Five™. Due to the advantages of S2 cells, particularly for secreted and secretable proteins, the lack of a simple and parallelizable S2-based platform represents a bottleneck, particularly for biochemical and biophysical laboratories. Therefore, we developed FAS2FURIOUS, a simple and rapid S2 expression pipeline built upon an existing low-throughput commercial platform. FAS2FURIOUS is comparable in effort to simple <jats:italic>E. coli</jats:italic> systems and allows users to clone and test up to 46 constructs in just 2 weeks. Given the ability of S2 cells to express challenging targets, including receptor ectodomains, secreted glycoproteins, and viral antigens, FAS2FURIOUS represents an attractive orthogonal approach for protein expression in eukaryotic cells.</jats:p>
  • Zugangsstatus: Freier Zugang